Fredun Pharmaceuticals H1 FY27 Results
Auto Added by WPeMatico
Business
Fredun Pharmaceuticals EBITDA Growth
Fredun Pharmaceuticals H1 FY27 Results
Fredun Pharmaceuticals Net Profit
Fredun Pharmaceuticals Revenue Growth
Indian pharmaceutical industry
Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27
Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]
Read More